The Gross Margin of Anika Therapeutics Inc (ANIK) is 63.89%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 63.89% |
2023-12-31 | 49.52% |
2022-12-31 | 59.92% |
2021-12-31 | 56.09% |
2020-12-31 | 52.87% |
2019-12-31 | 74.96% |
2018-12-31 | 70.36% |
2017-12-31 | 75.93% |
2016-12-31 | 76.79% |
2015-12-31 | 77.31% |